Geneos Wealth Management Inc. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$1,203,000
+1.5%
27,513
+1.1%
0.06%
+15.7%
Q1 2022$1,185,000
-2.2%
27,225
-0.9%
0.05%
+10.9%
Q4 2021$1,212,000
+14.8%
27,485
-0.8%
0.05%
+15.0%
Q3 2021$1,056,000
-4.9%
27,700
+0.8%
0.04%
-7.0%
Q2 2021$1,110,000
+0.8%
27,476
-6.8%
0.04%
+38.7%
Q1 2021$1,101,000
+10.5%
29,495
+5.8%
0.03%
-22.5%
Q4 2020$996,000
-1.0%
27,888
+4.8%
0.04%
-23.1%
Q3 2020$1,006,000
-11.2%
26,622
-4.8%
0.05%
-17.5%
Q2 2020$1,133,000
+84.5%
27,952
+65.7%
0.06%
+53.7%
Q1 2020$614,000
-26.9%
16,874
-5.1%
0.04%
-8.9%
Q4 2019$840,000
+12.0%
17,774
+0.2%
0.04%0.0%
Q3 2019$750,000
+7.8%
17,730
+1.9%
0.04%
+4.7%
Q2 2019$696,000
-5.6%
17,395
-1.4%
0.04%
-12.2%
Q1 2019$737,000
+13.0%
17,646
+3.2%
0.05%
+2.1%
Q4 2018$652,000
+19.9%
17,096
+26.2%
0.05%
+33.3%
Q3 2018$544,000
+15.7%
13,549
+16.2%
0.04%
-2.7%
Q2 2018$470,000
+5.1%
11,662
+1.9%
0.04%
-5.1%
Q1 2018$447,000
+7.2%
11,442
-2.8%
0.04%
+5.4%
Q4 2017$417,000
-16.1%
11,770
-3.9%
0.04%
-24.5%
Q3 2017$497,000
-7.6%
12,245
-1.9%
0.05%
-10.9%
Q2 2017$538,000
+1.7%
12,481
-0.6%
0.06%0.0%
Q1 2017$529,000
-24.8%
12,552
-31.3%
0.06%
-40.9%
Q4 2016$703,000
+126.8%
18,269
+154.1%
0.09%
+121.4%
Q3 2016$310,000
+13.1%
7,190
+13.0%
0.04%
+5.0%
Q2 2016$274,000
-15.4%
6,361
-20.9%
0.04%
-20.0%
Q1 2016$324,0008,0460.05%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders